Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 33(3): 369-77, 2014 Jan 16.
Article in English | MEDLINE | ID: mdl-23318418

ABSTRACT

The microbial pattern-recognizing Toll-like receptors (TLRs) are major signal transducers known to shape and influence the postnatal maturation of host intestinal epithelium. Perturbations in this intricate host-microbe cross-talk have been reported to be associated with uncontrolled epithelial cell growth and thus potential cancer development by mechanisms which are largely unknown. We therefore generated transgenic mice carrying a constitutively active TLR4 (CD4-TLR4) linked to an intestinal epithelial cell-specific promoter. Ex vivo analysis of transgenic crypt-villus organoid cultures revealed an increased proliferative capacity and a lowered cyclooxygenase 2 (Cox-2) expression in these organoids compared with wild-type control cultures. Introducing the CD4-TLR4 transgene into APC(Min/+) mice (CD4-TLR4-APC(Min/+)), a model of colorectal carcinoma, resulted in a dramatic drop in tumor load as compared with control APC(Min/+) mice. Intestinal tumors from CD4-TLR4-APC(Min/+) mice displayed reduced Cox-2 protein, elevated interferon ß expression and increased caspase-3 activity, which correlated with increased apoptosis in vivo. Thus, our data reveal that host microbiota-mediated signal transduction via TLR4 in intestinal epithelial cells is far more complex than what is previously reported.


Subject(s)
Apoptosis , Intestinal Mucosa/metabolism , Signal Transduction , Toll-Like Receptor 4/metabolism , Adenomatous Polyposis Coli Protein/genetics , Adenomatous Polyposis Coli Protein/metabolism , Animals , Caspase 3/metabolism , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Cells, Cultured , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Cyclooxygenase 2/metabolism , Female , Humans , Immunoblotting , Immunohistochemistry , Interferon-beta/metabolism , Intestinal Mucosa/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Mice, Transgenic , Organoids/cytology , Organoids/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Toll-Like Receptor 4/genetics , Tumor Burden/genetics
2.
Oncogene ; 32(10): 1233-9, 2013 Mar 07.
Article in English | MEDLINE | ID: mdl-22614012

ABSTRACT

Evidence that lipocalin 2 (LCN2) is oncogenic has grown in recent years and comes from both animal models and expression analysis from a variety of human cancers. In the intestine, LCN2 is overexpressed in colitis patients and its overexpression is a negative prognostic indicator in colorectal cancer. Functionally, LCN2 has a number of different activities that may contribute to its oncogenic potential, including increasing matrix metalloproteinase activity, control of iron availability and stimulating inflammation. In this report, we examined APCmin intestinal tumorigenesis in an LCN2-deficient background. We found that the loss of LCN2 increased tumor multiplicity specifically in the duodenum, suggesting a potential tumor-suppressive activity. Concurrently, however, LCN2 increased the average small intestinal tumor size particularly in the distal small intestine. We found that this increase was correlated to tumor iron(II) content, suggesting that an iron-scavenging role is important for LCN2 oncogenic activity in the intestine.


Subject(s)
Acute-Phase Proteins/biosynthesis , Intestinal Neoplasms/metabolism , Intestinal Neoplasms/pathology , Lipocalins/biosynthesis , Oncogene Proteins/biosynthesis , Acute-Phase Proteins/deficiency , Acute-Phase Proteins/genetics , Animals , Apoptosis/physiology , Disease Progression , Female , Genes, APC , Intestinal Neoplasms/genetics , Lipocalin-2 , Lipocalins/genetics , Male , Mice , Mice, Inbred C57BL , Oncogene Proteins/deficiency , Oncogene Proteins/genetics
3.
Blood ; 98(4): 1086-94, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11493455

ABSTRACT

Patients with the immunodeficiency disorder Wiskott-Aldrich syndrome (WAS) have lymphocytes with aberrant microvilli, and their T cells, macrophages, and dendritic cells are impaired in cytoskeletal-dependent processes. WAS is caused by a defective or a missing WAS protein (WASP). Signal mediators interleukin-4 (IL-4) and CD40 are important for actin-dependent morphology changes in B cells. A possible function of WASP and its interacting partners, Cdc42 and Rac1, was investigated for these changes. It was found that active Cdc42 and Rac1 induced filopodia and lamellipodia, respectively, in activated B cells. Evidence is given that IL-4 has a specific role in the regulated cycling of Cdc42 because IL-4 partially and transiently depleted active Cdc42 from detergent extract of activated B cells. WASP-deficient B lymphocytes were impaired in IL-4-- and CD40-dependent induction of polarized and spread cells. Microvilli were expressed on WASP-deficient B cells, but they appeared shorter and less dense in cell contacts than in wild-type cells. In conclusion, evidence is provided for the involvement of Cdc42, Rac1, and WASP in the cytoskeletal regulation of B lymphocytes. Aberrations in WASP-deficient B lymphocytes, described here, provide further evidence that WAS is a cytoskeletal disease of hematopoietic cells. (Blood. 2001;98:1086-1094)


Subject(s)
B-Lymphocytes/drug effects , Cytoskeleton/drug effects , Proteins/pharmacology , cdc42 GTP-Binding Protein/pharmacology , rac1 GTP-Binding Protein/pharmacology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/ultrastructure , CD40 Antigens/pharmacology , Cell Adhesion/drug effects , Cell Movement/drug effects , Cell Polarity/drug effects , Interleukin-4/pharmacology , Mice , Mice, Knockout , Microvilli/drug effects , Nerve Tissue Proteins/metabolism , Proteins/physiology , Signal Transduction/drug effects , Wiskott-Aldrich Syndrome/pathology , Wiskott-Aldrich Syndrome Protein , Wiskott-Aldrich Syndrome Protein, Neuronal , cdc42 GTP-Binding Protein/drug effects , cdc42 GTP-Binding Protein/physiology , rac1 GTP-Binding Protein/physiology , rho GTP-Binding Proteins/pharmacology , rho GTP-Binding Proteins/physiology
4.
Int Immunol ; 12(7): 995-1003, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10882411

ABSTRACT

During lymphocyte activation, changes in cell morphology are commonly observed. This reflects cell functions important for the regulation of immune responses such as cell adhesion or cell migration. Notably, IL-4 has been shown to induce adhesion and locomotion in B cells, and we have recently described that IL-4 causes dramatic changes in B cell morphology. Thus, such B cells spread with dendritic cell protrusions and produce microvilli-like structures. The molecular mechanisms by which IL-4 induces these complex changes are currently unknown. Two signal transduction pathways are well described for IL-4, i.e. one involving insulin receptor substrate (IRS)-2 and a Janus kinase (JAK)/ signal transducer and activator of transcription (STAT) pathway mediated by STAT6. In this study we therefore used B cells from STAT6-deficient mice to address the question of a possible STAT6 dependence in IL-4-induced morphology changes. By light and electron microscopy, cell spreading and polarization were found to be severely impaired and microvilli formation was reduced. In contrast, only mild impairment was observed in cell adhesion in B cells from STAT6-deficient mice. Our results show that adhesion can be induced in the absence of STAT6. However, expression of STAT6 is necessary for optimal responses in both cell adhesion and microvilli induction. STAT6 is also essential to allow an IL-4-dependent spreading or polarization response. A possible interpretation of our results is that STAT6-dependent expression of a specific gene or genes is required for IL-4 to affect changes in B cell morphology.


Subject(s)
B-Lymphocytes/drug effects , Cytoskeleton/drug effects , Interleukin-4/pharmacology , Trans-Activators/physiology , Animals , B-Lymphocytes/pathology , B-Lymphocytes/physiology , Cells, Cultured , DNA/biosynthesis , Insulin Receptor Substrate Proteins , Intracellular Signaling Peptides and Proteins , Lipopolysaccharides/pharmacology , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Phosphoproteins/physiology , Receptors, Interleukin-4/analysis , STAT6 Transcription Factor
5.
Scand J Immunol ; 48(6): 642-50, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9874499

ABSTRACT

In this study we investigated how T-cell-dependent stimuli, via interleukin-4 (IL-4) or CD40 ligation, influence homotypic B-cell adhesion when compared with induction by the T-cell-independent stimulus lipopolysaccharide (LPS). Using primary murine B cells, we found that T-cell-dependent stimulation led to increased aggregation as compared to that induced by LPS. The adhesion was to a large extent dependent on the adhesion molecule, lymphocyte function-associated antigen-1 (LFA-1). We found that activation of B cells with the mitogenic stimuli induced an increased avidity of LFA-1 for its ligand, intercellular adhesion molecule-1 (ICAM-1). The increase was stable and different from that induced by phorbol esters. Although adhesion was reduced using B cells from LFA-1(-/-) mice, aggregation occurred in response to T-cell-dependent stimuli. Our data suggest that adhesion of B lymphocytes is regulated in different modes. One is induced by antigen and leads to a transient conformational change of the LFA-1 molecule. Another is induced by mitogenic stimuli and leads to stable avidity increase of LFA-1, possibly via activation of cytoskeletal anchorage. A third is LFA-1 independent, of low avidity and is induced by T-cell-dependent stimuli.


Subject(s)
B-Lymphocytes/physiology , Lymphocyte Function-Associated Antigen-1/physiology , Animals , Cell Adhesion , Cells, Cultured , Female , Lymphocyte Activation , Lymphocyte Function-Associated Antigen-1/genetics , Lymphocyte Function-Associated Antigen-1/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Knockout
SELECTION OF CITATIONS
SEARCH DETAIL
...